Clinical trial · Observational
MIDNOR-STROKE- a Long Term Follow-up Study of Patients With First Ever Ischemic Stroke in Central Norway
MIDNOR-STROKE A Prospective Observation Study of a Cohort of 800 Patients With First Ever Ischemic Stroke in Central Norway
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Annually 13000 Norwegians experience an ischemic stroke. The number of stroke is anticipated to increase with 50% within 2030 due to a growing number of elderly. Many of them will have severe function deficits and reduced quality of life. The investigators have established a cohort consisting of 800 patients with first time ischemic stroke treated at hospitals in Central Norway. The investigators want to study the incidence and prognostic markers for death, recurrent stroke and severe functional deficits during a period of 10 years after the initial ischemic stroke. The investigators want to focus on the impact of physical functioning, the level of physical activity and use of medication for secondary prevention on the incidence of death, recurrent stroke and severe functional deficits. The investigators are especially interested in the importance of fulfilling the treatment targets for blood pressure and cholesterol and the importance of smoking cessation in stroke survivors. Our objective is to improve todays stroke treatment and achieve a more efficient use of the health resources in order to increase survival after stroke maintaining a good physical and psychological function and quality of life.
Conditions
Conditions (9)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Brain Ischemia | — | UNRESOLVED | — |
| Cardiovascular Diseases | — | UNRESOLVED | — |
| Cardiovascular Risk Factor | — | UNRESOLVED | — |
| Central Nervous System Lymphoma | Central Nervous System Lymphoma | ONTOLOGY_EXACT | 0.90 |
| Cerebrovascular Disorders | — | UNRESOLVED | — |
| Nervous System Diseases | — | UNRESOLVED | — |
| Pathologic Processes | — | UNRESOLVED | — |
| Stroke | — | UNRESOLVED | — |
| Vascular Diseases | — | UNRESOLVED |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| no intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- First time ischemic stroke
- description
- Patients with a first event of ischemic stroke admitted to hospitals in Central Norway.
- interventionNames
- Other: no intervention
Primary outcomes (20)
- measure
- The incidence of recurrent stroke after first ever ischemic stroke
- timeFrame
- 3 months
- description
- Measured by using data from the Norwegian Stroke Registry and other Norwegian Cardiovascular registries including patient questionnaires
- measure
- The incidence of recurrent stroke after first ever ischemic stroke
- timeFrame
- 1 year
- description
- Measured by using data from the Norwegian Stroke Registry and other Norwegian Cardiovascular registries including patient questionnaires
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion criteria: * Cerebral infarction according to ICD-10 CM code I63 * \> 18 years of age * First time stroke resident in Central-Norway * Recruited within a time frame of 7 days of hospital admission. Exclusion criteria: * Focal neurological symptoms turned out to be not stroke-related * Significant physical disabilities prior to stroke (defined as Modified Rankin ≥5).
References
Publications (0)
Data not yet available